GLP1R and metabolic dysfunction-associated steatotic liver disease: This is consistent with the presence of GLP-1 receptors in human immortalized hepatocytes, namely HepG2 and Huh7 [58,59,60], and indicates that GLP-1 can have a direct effect on improving NAFLD in the liver independent of its role in body weight reduction.